ZA958532B - Compounds having a 1-(arylalkenyl)-4-(arylmethyl)piperazine structure process and preparing them and pharmaceutical compositions containing them - Google Patents

Compounds having a 1-(arylalkenyl)-4-(arylmethyl)piperazine structure process and preparing them and pharmaceutical compositions containing them

Info

Publication number
ZA958532B
ZA958532B ZA958532A ZA958532A ZA958532B ZA 958532 B ZA958532 B ZA 958532B ZA 958532 A ZA958532 A ZA 958532A ZA 958532 A ZA958532 A ZA 958532A ZA 958532 B ZA958532 B ZA 958532B
Authority
ZA
South Africa
Prior art keywords
arylmethyl
arylalkenyl
preparing
compounds
pharmaceutical compositions
Prior art date
Application number
ZA958532A
Inventor
Genevieve Baziard-Mouysset
Sallouma Younes
Youssef Labssita
Marc Payard
Daniel-Henri Caignard
Pierre Renard
Marie-Claire Rettori
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA958532B publication Critical patent/ZA958532B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA958532A 1994-10-10 1995-10-10 Compounds having a 1-(arylalkenyl)-4-(arylmethyl)piperazine structure process and preparing them and pharmaceutical compositions containing them ZA958532B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412053A FR2725445B1 (en) 1994-10-10 1994-10-10 NOVEL DERIVATIVES WITH A 1-ARYLALKENYL 4-ARYL ALKYL PIPERAZINE STRUCTURE, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
ZA958532B true ZA958532B (en) 1996-05-10

Family

ID=9467706

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958532A ZA958532B (en) 1994-10-10 1995-10-10 Compounds having a 1-(arylalkenyl)-4-(arylmethyl)piperazine structure process and preparing them and pharmaceutical compositions containing them

Country Status (10)

Country Link
EP (1) EP0707004A1 (en)
JP (1) JP3035475B2 (en)
CN (1) CN1053441C (en)
AU (1) AU692594B2 (en)
CA (1) CA2160214A1 (en)
FI (1) FI954719A (en)
FR (1) FR2725445B1 (en)
NO (1) NO305699B1 (en)
NZ (1) NZ280192A (en)
ZA (1) ZA958532B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751645B1 (en) * 1996-07-29 1998-12-24 Sanofi Sa AMINES FOR THE MANUFACTURE OF DRUGS TO PREVENT THE PROLIFERATION OF TUMOR CELLS
GB0224917D0 (en) * 2002-10-25 2002-12-04 Novartis Ag Organic compounds
SE0400440D0 (en) * 2004-02-25 2004-02-25 Active Biotech Ab Novel Cinnamic Amides
US20110065749A1 (en) * 2008-06-04 2011-03-17 Active Co. Ltd. Method and pharmaceutical composition for treatment of mental disorders
CA3192518A1 (en) 2020-09-17 2022-03-24 Xavier MANIERE Compounds for treating virus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219577A (en) * 1985-07-16 1987-01-28 Kanebo Ltd Novel benzylpiperazine derivative and drug composition comprising same as active ingredient
EP0551617A3 (en) * 1991-12-13 1993-11-03 Ube Industries Cinnamyl piperazine derivatives method of manufacturing the same and agricultural/horticultural fungicides containing cinnamyl piperazine derivatives

Also Published As

Publication number Publication date
NO954010L (en) 1996-04-11
JPH08176129A (en) 1996-07-09
CN1133288A (en) 1996-10-16
FI954719A0 (en) 1995-10-04
JP3035475B2 (en) 2000-04-24
FR2725445A1 (en) 1996-04-12
NZ280192A (en) 1996-02-27
FR2725445B1 (en) 1996-10-31
EP0707004A1 (en) 1996-04-17
NO305699B1 (en) 1999-07-12
CA2160214A1 (en) 1996-04-11
CN1053441C (en) 2000-06-14
AU692594B2 (en) 1998-06-11
AU3311495A (en) 1996-04-26
FI954719A (en) 1996-04-11
NO954010D0 (en) 1995-10-09

Similar Documents

Publication Publication Date Title
HUP9802985A3 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives, pharmaceutical compositions containing them and process for producing them
HUP9902471A3 (en) Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing the same
ZA962438B (en) Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same
AU1667795A (en) Pharmaceutical piperazine compounds
GB9500075D0 (en) Process for making microdenominated cellulose
HUT76326A (en) Emulsions containing cyclodextrin as mucoadhesive and a drug and process for preparing them
HUP9602489A3 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0000088A3 (en) N-substituted azaheterocyclic compounds, process for producing them and pharmaceutical compositions containing them
IL116518A0 (en) Piperazine derivatives pharmaceutical compositions containing them their use and processes for preparing them
NZ325845A (en) 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof
ZA952046B (en) Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them
AU1667595A (en) Pharmaceutical piperazine compounds
EP0483580A3 (en) 1-(2-arylethyl)-pyrrolidine
HU9402187D0 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them
ZA948520B (en) 1-[2H-1-benzopyran-2one-8-yl]-piperazine derivatives
IL112639A0 (en) A pharmaceutical composition containing pravastin
HUP9702341A3 (en) New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them
ZA958532B (en) Compounds having a 1-(arylalkenyl)-4-(arylmethyl)piperazine structure process and preparing them and pharmaceutical compositions containing them
HUP9901208A3 (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methyl-amino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
GB2248838B (en) A new 5H-benzodiazepine derivative,pharmaceutical compositions containing same and process for preparing them
ZA933638B (en) Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
AU8725591A (en) Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
HU9402535D0 (en) Process for producing vinpocetine complexes and pharmaceutical compositions containing them
ZA884984B (en) 1-(2-(phenylmethyl)phenyl)piperazine compounds,a process for preparing them and pharmaceutical compositions containing them
HU9500453D0 (en) 1-[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine derivatives, process for preparing them and their medical use